HEALTHY EXTRACTS INC. (HYEX)

OTC Pharmaceutical Pharmaceutical Chemicals SIC: 2833
D
Pipeline Grade

Financial Position (from SEC Filings)

$0.2M
Cash & Equivalents
$0.1M
Quarterly Burn Rate
$37M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

DateEventDrug
2026-08-01 Phase2 Readout —

Active Clinical Trials (2)

NCT #TitlePhaseStatusEnrollment
NCT07428889 Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement OTHER Recruiting 34
NCT06889753 A Clinical Trial to Investigate the Effect of Pollen Extracts on Menopausal Symptoms in Healthy Women. PHASE2 Recruiting 120

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for HYEX.

SEC EDGAR Filings

All SEC filings for HEALTHY EXTRACTS INC. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.